About Fluence Therapeutics
Fluence Therapeutics was a Healthcare company based in Akron (United States) founded in 2009. It provides photodynamic therapy solutions for treating psoriasis and other skin conditions effectively. It operates on a B2B model. Fluence Therapeutics has raised $150 thousand across 2 funding rounds from investors including Innovation Fund America. The company is recorded as dissolved. Its focus areas include Biotechnology, Therapeutics and Dermatology Treatments. Its legal entity is Fluence Therapeutics Inc. Its competitors include Revian, Omnilux Medical and TheraLight.
Company details
Fluence Therapeutics, established in 2009, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and dermatology treatments. Provides photodynamic therapy solutions for treating psoriasis and other skin conditions effectively. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Akron, United States
- SectorsHealthcare
- Website fluencetherapeutics.com
- Legal Name Fluence Therapeutics Inc.
- Total Equity Funding$150K (USD)
in 2 rounds
- Latest Funding Round$150K (USD), Seed
May 2013
- Investors
Funding Insights of Fluence Therapeutics
Fluence Therapeutics has successfully raised a total of $150K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $150 thousand completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150,000
- Total Rounds 2
- Last Round Seed — $150,000
- First Round $25,000
(May 2010)
- Investors Count 1
All 2 funding rounds of Fluence Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2013 | $150,000 | Seed | – | – | – |
| May 2010 | $25,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Fluence Therapeutics
Fluence Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Innovation Fund America.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life Science focused seed stage VC firm investing in the US | innovationfundamerica.org | Elyria, United States |
Investor details for Fluence Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Fluence Therapeutics
3 dated milestones of Fluence Therapeutics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Fluence Therapeutics is founded.
- Funding First funding round of $25K.
- Funding Latest funding round, Seed, of $150K.
Competitors of Fluence Therapeutics
Fluence Therapeutics has 3 listed competitors in our database. They include Revian, Omnilux Medical and TheraLight.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| revian.com | 2016 | Durham, United States | 36 | Offers light-based devices for treating hair loss at home effectively. | ||
| omniluxmedical.com | 2003 | Napa, United States | LED phototherapy systems for skin diseases are developed. | |||
| theralight.com | 1999 | Lindon, United States | Provides red light therapy beds to promote cellular health and reduce oxidative stress. |
Detailed competitors of Fluence Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as Fluence Therapeutics (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fluence Therapeutics
Fluence Therapeutics was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Fluence Therapeutics is headquartered in Akron, United States. It is registered at Akron, Ohio, United States.
Fluence Therapeutics is a funded company, having raised a total of $150K across 2 funding rounds to date. The company's 1st funding round was a Grant of $25K, raised on May 2010.
Fluence Therapeutics, established in 2009, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and dermatology treatments. Provides photodynamic therapy solutions for treating psoriasis and other skin conditions effectively. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Fluence Therapeutics's top competitors include Omnilux Medical, Revian and TheraLight.
Fluence Therapeutics has 1 investor. Key investors include Innovation Fund America.
Fluence Therapeutics operates through Fluence Therapeutics Inc..